• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加速实现喀麦隆三个 95 艾滋病毒目标的研究重点:喀麦隆艾滋病毒研究论坛(CAM-HERO)的共识声明。

Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO).

机构信息

Clinical Research Education, Networking and Consultancy, Yaoundé, Cameroon.

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

出版信息

Pan Afr Med J. 2021 Oct 29;40:124. doi: 10.11604/pamj.2021.40.124.31068. eCollection 2021.

DOI:10.11604/pamj.2021.40.124.31068
PMID:34909092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8641633/
Abstract

INTRODUCTION

the Treat-All remains the globally endorsed approach to attain the 95-95-95 targets and end the AIDS pandemic by 2030, but requires some country-level contextualization. In Cameroon, the specific research agenda to inform strategies for improving HIV policy was yet to be defined.

METHODS

under the patronage of the Cameroon Ministry of health, researchers, policy makers, implementing partners, and clinicians from 13 institutions, used the Delphi method to arrive at a consensus of HIV research priorities. The process had five steps: 1) independent literature scan by 5 working groups; 2) review of the initial priority list; 3) appraisal of priorities list in a larger group; 4) refinement and consolidation by a consensus group; 5) rating of top research priorities.

RESULTS

five research priorities and corresponding research approaches, resulted from the process. These include: 1) effectiveness, safety and active toxicity monitoring of new and old antiretrovirals; 2) outcomes of Antiretroviral Therapy (ART) with focus in children and adolescents; 3) impact of HIV and ART on aging and major chronic diseases; 4) ART dispensation models and impact on adherence and retention; 5) evaluations of HIV treatment and prevention programs.

CONCLUSION

the research priorities resulted from a consensus amongst a multidisciplinary team and were based on current data about the pandemic and science to prevent, treat, and ultimately cure HIV. These priorities highlighted critical areas of investigation with potential relevance for the country, funders, and regulatory bodies.

摘要

简介

全面治疗仍然是全球认可的方法,旨在实现 95-95-95 目标,到 2030 年终结艾滋病流行,但需要在国家层面进行一些调整。在喀麦隆,为改进艾滋病毒政策提供信息的具体研究议程尚未确定。

方法

在喀麦隆卫生部的赞助下,来自 13 个机构的研究人员、政策制定者、实施伙伴和临床医生使用德尔菲法达成了艾滋病毒研究重点的共识。该过程分为五个步骤:1)5 个工作组进行独立文献扫描;2)审查初始优先事项清单;3)在更大的群体中评估优先事项清单;4)由共识小组进行改进和整合;5)对研究重点进行评级。

结果

该过程产生了五项研究重点和相应的研究方法,包括:1)新老抗逆转录病毒药物的有效性、安全性和主动毒性监测;2)抗逆转录病毒疗法(ART)的结果,重点关注儿童和青少年;3)艾滋病毒和 ART 对衰老和主要慢性疾病的影响;4)ART 配给模式及其对依从性和保留率的影响;5)艾滋病毒治疗和预防方案的评估。

结论

这些研究重点是由多学科团队达成的共识,并基于当前关于大流行和科学的相关数据,旨在预防、治疗和最终治愈艾滋病毒。这些重点突出了具有国家、资助者和监管机构相关性的重要研究领域。

相似文献

1
Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO).加速实现喀麦隆三个 95 艾滋病毒目标的研究重点:喀麦隆艾滋病毒研究论坛(CAM-HERO)的共识声明。
Pan Afr Med J. 2021 Oct 29;40:124. doi: 10.11604/pamj.2021.40.124.31068. eCollection 2021.
2
Evidence for an enhanced HIV/AIDS policy and care in Cameroon: proceedings of the second Cameroon HIV Research Forum (CAM-HERO) 2021.有证据表明喀麦隆加强了艾滋病毒/艾滋病政策和护理:2021 年第二届喀麦隆艾滋病毒研究论坛(CAM-HERO)会议记录。
Pan Afr Med J. 2022 Oct 20;43:92. doi: 10.11604/pamj.2022.43.92.37080. eCollection 2022.
3
Research priorities to inform "Treat All" policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA).指导撒哈拉以南非洲地区艾滋病毒感染者实施“全面治疗”政策的研究重点:来自国际艾滋病流行病学数据库评估组织(IeDEA)的共识声明。
J Int AIDS Soc. 2019 Jan;22(1):e25218. doi: 10.1002/jia2.25218.
4
Research for Health Care and Policy on HIV/AIDS: proceedings of the third edition of the Cameroon HIV Research (CAM-HERO) 2022, Kribi, Cameroon, from 1 to 3 December 2022.艾滋病毒/艾滋病保健和政策研究:2022 年 12 月 1 日至 3 日在喀麦隆克里比举行的第三届喀麦隆艾滋病毒研究(CAM-HERO)会议记录。
Pan Afr Med J. 2023 Sep 6;46:6. doi: 10.11604/pamj.2023.46.6.40711. eCollection 2023.
5
Outcomes of the first meeting of the CAMEROON HIV RESEARCH FORUM (CAM-HERO).喀麦隆艾滋病毒研究论坛(CAM-HERO)第一次会议的结果。
Pan Afr Med J. 2021 Nov 17;40:166. doi: 10.11604/pamj.2021.40.166.31058. eCollection 2021.
6
Sustaining the community dispensation strategy of HIV antiretroviral through community participation.通过社区参与,维持艾滋病毒抗逆转录病毒的社区分发策略。
Infect Dis Poverty. 2019 Jan 24;8(1):5. doi: 10.1186/s40249-019-0518-8.
7
How countries cope with competing demands and expectations: perspectives of different stakeholders on priority setting and resource allocation for health in the era of HIV and AIDS.国家如何应对相互竞争的需求和期望:不同利益攸关方对艾滋病毒和艾滋病时代卫生重点制定和资源分配的看法。
BMC Public Health. 2012 Dec 11;12:1071. doi: 10.1186/1471-2458-12-1071.
8
Determinants of retention in HIV antiretroviral treatment (ART) in the Cameroon International epidemiology Database to Evaluate AIDS (IeDEA) study clinics: the context of the HIV treat all strategy in Cameroon.喀麦隆国际艾滋病流行病学数据库评估艾滋病(IeDEA)研究诊所中抗逆转录病毒治疗(ART)保留的决定因素:喀麦隆的 HIV 治疗所有策略背景。
Pan Afr Med J. 2021 Nov 2;40:129. doi: 10.11604/pamj.2021.40.129.22642. eCollection 2021.
9
Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).对接受一线和二线抗逆转录病毒治疗的青少年的治疗反应、耐药性及HIV-1变异性的评估:喀麦隆中部地区一项前瞻性观察性研究的研究方案(EDCTP READY研究)
BMC Pediatr. 2019 Jul 5;19(1):226. doi: 10.1186/s12887-019-1599-z.
10
Research Priorities for the Intersection of Alcohol and HIV/AIDS in Low and Middle Income Countries: A Priority Setting Exercise.低收入和中等收入国家酒精与艾滋病毒/艾滋病交叉领域的研究重点:一次确定优先事项的活动
AIDS Behav. 2017 Nov;21(Suppl 2):262-273. doi: 10.1007/s10461-017-1921-4.

引用本文的文献

1
Factors Associated with HIV Testing Uptake in Cameroon: Data from the 2018 Cameroon Demographic and Health Survey.喀麦隆艾滋病病毒检测接受情况的相关因素:来自2018年喀麦隆人口与健康调查的数据。
HIV AIDS (Auckl). 2025 Jan 22;17:9-17. doi: 10.2147/HIV.S496572. eCollection 2025.
2
Ten Recommendations for Accelerating Hypertension and Diabetes Control to Reduce Stroke, Heart, and Renal Disease with the Aim to Save Lives in Cameroon Through Partnerships and Collaborations.加速高血压和糖尿病控制以减少中风、心脏和肾脏疾病的十项建议,旨在通过伙伴关系和合作拯救喀麦隆人民的生命。
Adv Ther. 2024 Nov;41(11):3996-4007. doi: 10.1007/s12325-024-02960-4. Epub 2024 Sep 14.
3

本文引用的文献

1
Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis.多替拉韦与400mg依非韦伦在一线抗逆转录病毒治疗HIV中的疗效、耐受性和安全性比较:一项系统文献综述和网状Meta分析
EClinicalMedicine. 2020 Oct 16;28:100573. doi: 10.1016/j.eclinm.2020.100573. eCollection 2020 Nov.
2
Transition to Dolutegravir Is Associated With an Increase in the Rate of Body Mass Index Change in a Cohort of Virally Suppressed Adolescents.转为使用度鲁特韦后,病毒抑制的青少年队列中体重指数变化率上升。
Clin Infect Dis. 2021 Aug 2;73(3):e580-e586. doi: 10.1093/cid/ciaa1652.
3
Research for Health Care and Policy on HIV/AIDS: proceedings of the third edition of the Cameroon HIV Research (CAM-HERO) 2022, Kribi, Cameroon, from 1 to 3 December 2022.
艾滋病毒/艾滋病保健和政策研究:2022 年 12 月 1 日至 3 日在喀麦隆克里比举行的第三届喀麦隆艾滋病毒研究(CAM-HERO)会议记录。
Pan Afr Med J. 2023 Sep 6;46:6. doi: 10.11604/pamj.2023.46.6.40711. eCollection 2023.
4
Evidence for an enhanced HIV/AIDS policy and care in Cameroon: proceedings of the second Cameroon HIV Research Forum (CAM-HERO) 2021.有证据表明喀麦隆加强了艾滋病毒/艾滋病政策和护理:2021 年第二届喀麦隆艾滋病毒研究论坛(CAM-HERO)会议记录。
Pan Afr Med J. 2022 Oct 20;43:92. doi: 10.11604/pamj.2022.43.92.37080. eCollection 2022.
PASCAR and WHF Cardiovascular Diseases Scorecard project.
帕斯卡和世界心脏联盟心血管疾病记分卡项目。
Cardiovasc J Afr. 2020 Mar/Apr;31(2):103-110. doi: 10.5830/CVJA-2020-015.
4
Excessive Weight Gain Associated With Dolutegravir Initiation in a 10-Year-Old Female With Perinatally Acquired Human Immunodeficiency Virus: A Case Report and Review of the Literature.与替诺福韦二代多拉韦林起始治疗相关的过度体重增加:一例 10 岁母婴垂直传播人类免疫缺陷病毒感染女童病例报告并文献复习
J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):373-375. doi: 10.1093/jpids/piaa052.
5
Comorbidity of HIV, hypertension, and diabetes and associated factors among people receiving antiretroviral therapy in Bahir Dar city, Ethiopia.埃塞俄比亚巴赫达尔市接受抗逆转录病毒治疗人群中艾滋病毒、高血压和糖尿病的合并症及相关因素
J Comorb. 2020 Mar 15;10:2235042X19899319. doi: 10.1177/2235042X19899319. eCollection 2020 Jan-Dec.
6
Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon.喀麦隆病毒载量抑制和获得性艾滋病毒耐药性的全国估计数。
EClinicalMedicine. 2018 Jul 4;1:21-27. doi: 10.1016/j.eclinm.2018.06.005. eCollection 2018 Jul.
7
Blood pressure and burden of hypertension in Cameroon, a microcosm of Africa: a systematic review and meta-analysis of population-based studies.喀麦隆的血压和高血压负担:一个非洲的缩影:基于人群的研究的系统评价和荟萃分析。
J Hypertens. 2019 Nov;37(11):2190-2199. doi: 10.1097/HJH.0000000000002165.
8
Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy.初治人群开始使用多替拉韦为基础的抗逆转录病毒治疗时体重增加较多。
Clin Infect Dis. 2020 Mar 17;70(7):1267-1274. doi: 10.1093/cid/ciz407.
9
Assessing the causes of under-five mortality and proportion associated with pneumococcal diseases in Cameroon. A case-finding retrospective observational study: 2006-2012.评估喀麦隆五岁以下儿童死亡原因及其与肺炎球菌疾病相关的比例。一项病例发现回顾性观察研究:2006-2012 年。
PLoS One. 2019 Apr 17;14(4):e0212939. doi: 10.1371/journal.pone.0212939. eCollection 2019.
10
STRETCHing HIV treatment: A replication study of task shifting in South Africa.拉伸艾滋病治疗:南非任务转移的复制研究。
PLoS One. 2019 Apr 8;14(4):e0206677. doi: 10.1371/journal.pone.0206677. eCollection 2019.